Has Louis Kasunic received payments from drug or device companies?

Yes. Drug and device makers reported $4,471 in general payments to Louis Kasunic across 214 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Louis Kasunic did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Louis Kasunic come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Louis Kasunic

Family Medicine · Castle Rock, CONPI 1912083296

Payments from drug & device makers

$4,471in general payments, 2019–2025

Across 214 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$1K
Amarin Pharma, Inc.$411
AbbVie$404
Boehringer Ingelheim$263
Novo Nordisk$260
Pfizer$225
plus $2K from 35 others

What the payments were for

Food & beverage$4,40098%
Education$712%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	37	$1,023
Amarin Pharma, Inc.	5	$411
AbbVie(2 entities)	19	$404
Boehringer Ingelheim	14	$263
Novo Nordisk	16	$260
Pfizer	14	$225
Amgen(2 entities)	10	$183
Novartis	9	$177
Lilly USA, LLC	13	$175
GSK	7	$126
Johnson & Johnson	6	$116
Biohaven Pharmaceutical Holding Company Ltd.	4	$97
Sanofi-aventis U.S. LLC	5	$87
Merck	6	$82
Takeda Pharmaceuticals U.S.A., Inc.	4	$69
Amneal Pharmaceuticals LLC	4	$57
Bayer	3	$56
Medicure Pharma Inc.	3	$54
Biohaven Pharmaceuticals, Inc.	2	$54
Kowa Pharmaceuticals America, Inc.	3	$51
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$41
Clarus Therapeutics Inc.	3	$37
Avanir Pharmaceuticals, Inc.	2	$31
Adlon Therapeutics L.p.	2	$30
Abbott	2	$30
Antares Pharma, Inc.	2	$28
Avion Pharmaceuticals	2	$27
Neos Therapeutics, LP	1	$26
Exact Sciences	1	$24
Bausch Health US, LLC	1	$24
Sanofi Pasteur Inc.	1	$24
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$22
Shire North American Group Inc	1	$20
Vertical Pharmaceuticals, LLC	1	$20
Gilead	1	$20
Esperion Therapeutics, Inc.	1	$18
E.r. Squibb & Sons, L.L.C.	1	$18
IBSA Pharma Inc.	1	$17
Jazz Pharmaceuticals Inc.	1	$16
Teva Pharmaceuticals USA, Inc.	1	$14
Therapeuticsmd, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Vascepa$378
FARXIGA$246
BREZTRI$123

How this compares

$4,471 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado →

Other family medicine in Castle Rock

Larry OdekirkCastle Rock$6.3M
Belton HallmarkCastle Rock$19K
Aaron BlockCastle Rock$17K
Clint FlanaganDacono$7.6M
Ripley HollisterColorado Springs$5.5M
Timothy ColanderAurora$3.1M
Mia ScottDenver$993K
Matthew LewisAurora$960K
Ethan LazarusDenver$688K
Patrick BarryFraser$568K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →